<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0004349'>Reduced bone mineral density</z:hpo> in patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> is thought to be due to disturbances in calcium homeostasis or the effects of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> treatment </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To assess the prevalence and mechanism of <z:hpo ids='HP_0004349'>reduced bone mineral density</z:hpo> in 79 patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (44 with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, 35 with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>) who did not have significant risk factors for low bone densities </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Dual x ray absorptiometry was used to measure bone mineral density and serum and urinary markers of osteoblast (alkaline phosphatase, procollagen 1 carboxy terminal <z:chebi fb="7" ids="16670">peptide</z:chebi> and osteocalcin) and osteoclast (pyridinoline, deoxypyridinoline, and type 1 collagen carboxy terminal <z:chebi fb="7" ids="16670">peptide</z:chebi>) activities to assess bone turnover </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There was a high prevalence of low bone mineral density (prevalence of T scores &lt; -1.0 from 51%-77%; T scores &lt; -2.5 (<z:hpo ids='HP_0000939'>osteoporosis</z:hpo>) from 17%-28%) with hips being more often affected than vertebrae (p &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0004349'>Reduced bone mineral density</z:hpo> did not relate to concurrent or past <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> intake, or type, site, or severity of disease </plain></SENT>
<SENT sid="5" pm="."><plain>Whereas calcium homeostasis was <z:mpath ids='MPATH_458'>normal</z:mpath>, bone markers showed <z:hpo ids='HP_0002797'>increased bone resorption</z:hpo> without a compensatory increase in bone formation </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The greater prevalence of reduced hip bone mineral density, as opposed to vertebral, mineral density and the pattern of a selective increase in bone resorption contrasts with that found in other known causes of <z:e sem="disease" ids="C0005944" disease_type="Disease or Syndrome" abbrv="">metabolic bone disease</z:e> </plain></SENT>
</text></document>